Company Aequus Pharmaceuticals Inc Toronto S.E.
Equities
CA0076361033
Pharmaceuticals
Business Summary
Sales per Business
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Drugs
100.0
%
| 0 | 17.6 % | 0 | 100.0 % | +5.01% |
Sales per region
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Canada
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -81.53% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Anne Stevens
FOU | Founder | - | 12-12-31 |
Douglas Janzen
CEO | Chief Executive Officer | 56 | 13-01-02 |
Ann Fehr
DFI | Director of Finance/CFO | 55 | 16-07-21 |
Andre Mbeng
AUD | Comptroller/Controller/Auditor | 45 | 20-10-31 |
Grant Larsen
PRN | Corporate Officer/Principal | - | 20-08-16 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Douglas Janzen
CEO | Chief Executive Officer | 56 | 13-01-02 |
Marc Lustig
BRD | Director/Board Member | 51 | 21-02-14 |
Director/Board Member | 54 | 14-12-17 | |
Anne Stevens
FOU | Founder | - | 12-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 132,634,431 | 113,163,965 ( 85.32 %) | 0 | 85.32 % |
Company contact information
Aequus Pharmaceuticals, Inc.
200 Granville Street Suite 2820
V6C 1S4, Vancouver
+604 336 7906
http://www.aequuspharma.caSector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+31.37% | 588B | |
-2.76% | 364B | |
+20.58% | 326B | |
+5.58% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+11.11% | 167B | |
+0.10% | 161B |